{
  "nctId": "NCT02374476",
  "briefTitle": "Bipolar Ventricular Tachycardia (VT) Study",
  "officialTitle": "Bipolar Catheter Ablation for the Treatment of Refractory Scar-Related Ventricular Arrhythmia",
  "protocolDocument": {
    "nctId": "NCT02374476",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2016-08-24",
    "uploadDate": "2022-07-07T08:52",
    "size": 473879,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02374476/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NON_RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 145,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-02-18",
    "completionDate": "2020-09-30",
    "primaryCompletionDate": "2020-04-01",
    "firstSubmitDate": "2015-02-23",
    "firstPostDate": "2015-02-27"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* â‰¥ 18 years of age.\n* The study will include all forms of scar VT--both ischemic (post-myocardial infarction) and non-ischemic (eg sarcoid, amyloid, dilated)--as determined by cardiac MRI and/or voltage mapping at the time of VT ablation.\n* Intramural VT not terminable with unipolar ablation once enrolled in the Bipolar study or previous failed unipolar ablation within 6 months prior to enrollment.\n* Ability to understand the requirements of the study and sign the informed consent form.\n* Willingness to adhere to study restrictions and comply with all post- procedural follow-up requirements\n* Projected lifespan greater than 1 year.\n\nExclusion Criteria:\n\n* Tissue Thickness less than 5 mm as assessed by electroanatomic mapping, CT, or MRI.\n* MI or CABG within 6 weeks.\n* NYHA Class IV CHF.\n* Women known to be pregnant or to have positive beta-HCG.\n* Participation in another study that would interfere with this study.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Number of Participants Achieving Freedom From Recurrent Ventricular Tachycardia (VT)",
        "description": "Freedom from recurrent VT at 6 months, defined as sustained ventricular tachycardia lasting longer than 30 seconds and identified due to clinical symptoms or during device interrogation.",
        "timeFrame": "6 months"
      }
    ],
    "secondary": [
      {
        "measure": "Number of Procedural Complications",
        "description": "Total number of procedural complications which includes death, stroke, MI, heart failure, conduction abnormalities, pericardial effusion requiring drainage, hematoma, pseudoaneurysm",
        "timeFrame": "6 months"
      },
      {
        "measure": "Number of Participants With Post-ablation Inducibility of VT",
        "description": "Number of participants to indicate incidence of the induction of any sustained arrhythmia post-ablation, with a duration \\> 15 seconds of monomorphic VT (MMVT). Post ablation inducibility is measured via program stimulation.",
        "timeFrame": "6 months"
      },
      {
        "measure": "Time to Arrhythmia Termination for the Bipolar Group Only",
        "description": "When bipolar ablation is performed during ongoing Ventricular Tachycardia (VT), the time to termination is the amount of ablation time that was necessary to cause VT to stop (terminate)",
        "timeFrame": "through termination, up to 60 seconds"
      },
      {
        "measure": "Total Duration of Bipolar Ablation",
        "description": "Duration of bipolar ablation is the total procedure time",
        "timeFrame": "average of 345 minutes"
      },
      {
        "measure": "Number of of Participants With Mortality",
        "description": "Number of participant from all cause mortality",
        "timeFrame": "6 months"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 5,
      "otherCount": 0,
      "totalCount": 6
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 39,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-21T22:34:19.203Z",
  "dataSource": "ClinicalTrials.gov API v2 - Mass Collection"
}